Risk of Cancer After CVD Diagnosis Varies by CVD Type and Cancer Type
Cardiovascular disease (CVD), particularly atherosclerotic CVD, is associated with an increased risk of multiple cancers, research suggests.
Cardiovascular disease (CVD), particularly atherosclerotic CVD, is associated with an increased risk of multiple cancers, research suggests.
After the BCG shortage began, patients with non-muscle invasive bladder cancer were less likely to receive a full course of induction with any drug.
Sequential treatment with BCG and mitomycin C appears effective in patients with high-risk nonmuscle-invasive bladder cancer.
The FDA has granted accelerated approval to Padcev with Keytruda for locally advanced or metastatic urothelial cancer.
The conversion from accelerated approval to regular approval was based on data from the KEYNOTE-158 trial, the KEYNOTE-164 trial, and the KEYNOTE-051 trial.
The median survival for patients with metastatic bladder cancer is increasing, possibly due to increasing use of immunotherapy.
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
Patients undergoing radical cystectomy for bladder cancer have an increased risk of thromboembolic events that may persist for months after surgery.
Total hospital costs related to radical cystectomy are higher in the West than in all other regions of the United States, a study suggests.
Aortic calcification may lead to arterial degradation that increases the risk for acute kidney injury, according to investigators.